These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 15227294)

  • 61. Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease.
    Horowitz LN; Greenspan AM; Spielman SR; Webb CR; Morganroth J; Rotmensch H; Sokoloff NM; Rae AP; Segal BL; Kay HR
    Am J Cardiol; 1985 Feb; 55(4):367-71. PubMed ID: 3969870
    [TBL] [Abstract][Full Text] [Related]  

  • 62. QT prolongation and the antiarrhythmic efficacy of amiodarone.
    Torres V; Tepper D; Flowers D; Wynn J; Lam S; Keefe D; Miura DS; Somberg JC
    J Am Coll Cardiol; 1986 Jan; 7(1):142-7. PubMed ID: 3941202
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Amiodarone: risk factors for recurrence of symptomatic ventricular tachycardia identified at electrophysiologic study.
    Naccarelli GV; Fineberg NS; Zipes DP; Heger JJ; Duncan G; Prystowsky EN
    J Am Coll Cardiol; 1985 Oct; 6(4):814-21. PubMed ID: 3928727
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Amiodarone and desethylamiodarone distribution in the atrium and adipose tissue of patients undergoing short- and long-term treatment with amiodarone.
    Barbieri E; Conti F; Zampieri P; Trevi GP; Zardini P; d'Aranno V; Latini R
    J Am Coll Cardiol; 1986 Jul; 8(1):210-3. PubMed ID: 3711518
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Side effects and complications of amiodarone therapy.
    Raeder EA; Podrid PJ; Lown B
    Am Heart J; 1985 May; 109(5 Pt 1):975-83. PubMed ID: 3158188
    [TBL] [Abstract][Full Text] [Related]  

  • 66. QT prolongation and arrhythmia suppression.
    Roden DM; Woosley RL
    Am Heart J; 1985 Feb; 109(2):411-5. PubMed ID: 2578242
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of amiodarone on thyroid function in patients with ischaemic heart disease.
    Pritchard DA; Singh BN; Hurley PJ
    Br Heart J; 1975 Aug; 37(8):856-60. PubMed ID: 1191447
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of amiodarone and L8040, novel antianginal and antiarrhythmic drugs, on cardiac and coronary haemodynamics and on cardiac intracellular potentials.
    Singh BN; Jewitt DE; Downey JM; Kirk ES; Sonnenblick EH
    Clin Exp Pharmacol Physiol; 1976; 3(5):427-42. PubMed ID: 975630
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical efficacy of amiodarone as an antiarrhythmic agent.
    Rosenbaum MB; Chiale PA; Halpern MS; Nau GJ; Przybylski J; Levi RJ; Lázzari JO; Elizari MV
    Am J Cardiol; 1976 Dec; 38(7):934-44. PubMed ID: 793369
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Electrophysiologic testing: predictive of amiodarone efficacy in recurrent sustained ventricular tachycardia?
    Mas IJ; Massumi A; Harlan M; Seger JJ; Hall RJ
    Tex Heart Inst J; 1987 Dec; 14(4):382-8. PubMed ID: 15227294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 4.